JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2003; 41:129-135
© 2003 by the American College of Cardiology Foundation
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Elhendy, A.
Right arrow Articles by Pellikka, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Elhendy, A.
Right arrow Articles by Pellikka, P. A.

CLINICAL STUDY: LEFT VENTRICULAR HYPERTROPHY

Prediction of mortality in patients with left ventricular hypertrophy by clinical, exercise stress, and echocardiographic data

Abdou Elhendy, MD, PhD*, Karen M. Modesto, MD*, Douglas W. Mahoney, MSc{dagger}, Bijoy K. Khandheria, MD*, James B. Seward, MD* and Patricia A. Pellikka, MD*,*

* Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA
{dagger} Department of Biostatistics, Mayo Clinic, Rochester, Minnesota, USA

Manuscript received February 8, 2002; revised manuscript received July 30, 2002, accepted September 26, 2002.

* Reprint requests and correspondence: Dr. Patricia A. Pellikka, Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic and Mayo Foundation, 200 1st Street SW, Rochester, Minnesota 55905, USA.
Pellikka.patricia{at}mayo.edu

OBJECTIVES: This study evaluated the clinical, exercise stress test, and echocardiographic predictors of mortality and cardiac events in patients with left ventricular hypertrophy (LVH).

BACKGROUND: Left ventricular hypertrophy is associated with an increased risk of cardiovascular morbidity and mortality.

METHODS: Symptom-limited treadmill exercise echocardiography was performed for evaluation of coronary artery disease in 483 patients (age, 66 ± 11 years; 281 men) with LVH. End points during follow-up were all-cause mortality and hard cardiac events (cardiac death and nonfatal myocardial infarction [MI]).

RESULTS: Forty-six patients died and 14 had nonfatal MI. The cumulative mortality rate was higher in patients with abnormal exercise echocardiography (3% vs. 0.4% at one year, 11.7% vs. 3.7% at three years, and 18.3% vs. 9.5% at five years, p < 0.001). In a sequential multivariate analysis model of clinical, exercise test, and rest and exercise echocardiographic data, incremental predictors of mortality were workload (hazard ratio [HR], 0.5; 95% confidence interval [CI], 0.3 to 0.9), rate pressure product (HR, 0.7; 95% CI, 0.5 to 0.9), left ventricular (LV) mass index (HR, 1.4; 95% CI, 1.1 to 1.8), and failure to increase ejection fraction (EF) with exercise (HR, 2.1; 95% CI, 1.1 to 3.8). Predictors of cardiac events were history of coronary artery bypass grafting (HR, 2.6; 95% CI, 1.2 to 5.4), lower exercise rate-pressure product (HR, 0.6; 95% CI, 0.5 to 0.8), resting wall motion score index (HR, 1.4; 95% CI, 1.1 to 1.8), and failure to increase EF with exercise (HR, 3.3; 95% CI, 1.6 to 6.9).

CONCLUSIONS: In patients with LVH, LV mass index and EF response to exercise are independent predictors of mortality, incremental to clinical and exercise test data and resting LV function. A normal exercise echocardiogram predicts a relatively low mortality rate during the following three years.

Abbreviations and Acronyms
  CAD
  coronary artery disease
  ECG
  electrocardiogram/electrocardiographic
  EF
  ejection fraction
  LV
  left ventricle/ventricular
  LVH
  left ventricular hypertrophy
  METs
  metabolic equivalents
  MI
  myocardial infarction




This article has been cited by other articles:


Home page
J CARDIOVASC PHARMACOL THERHome page
M. Unverdorben, A. van der Bijl, L. Potgieter, C. Venter, S. Munjal, Qiwei Liang, B. Meyer, and H.-J. Rothig
Effects of Different Levels of Cigarette Smoke Exposure on Prognostic Heart Rate and Rate--Pressure-Product Parameters
Journal of Cardiovascular Pharmacology and Therapeutics, September 1, 2008; 13(3): 175 - 182.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
L. D. Metz, M. Beattie, R. Hom, R. F. Redberg, D. Grady, and K. E. Fleischmann
The Prognostic Value of Normal Exercise Myocardial Perfusion Imaging and Exercise Echocardiography: A Meta-Analysis
J. Am. Coll. Cardiol., January 16, 2007; 49(2): 227 - 237.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
J. J. Augustine and D. E. Hricik
Anemia after Kidney Transplantation: Time for Action
J. Am. Soc. Nephrol., November 1, 2006; 17(11): 2962 - 2963.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. A. Alsaileek, M. Osranek, K. Fatema, R. B. McCully, T. S. Tsang, and J. B. Seward
Predictive Value of Normal Left Atrial Volume in Stress Echocardiography
J. Am. Coll. Cardiol., March 7, 2006; 47(5): 1024 - 1028.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
P. T. Vlagopoulos, H. Tighiouart, D. E. Weiner, J. Griffith, D. Pettitt, D. N. Salem, A. S. Levey, and M. J. Sarnak
Anemia as a Risk Factor for Cardiovascular Disease and All-Cause Mortality in Diabetes: The Impact of Chronic Kidney Disease
J. Am. Soc. Nephrol., November 1, 2005; 16(11): 3403 - 3410.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
I. S. Anand, M. A. Kuskowski, T. S. Rector, V. G. Florea, R. D. Glazer, A. Hester, Y. T. Chiang, N. Aknay, A. P. Maggioni, C. Opasich, et al.
Anemia and Change in Hemoglobin Over Time Related to Mortality and Morbidity in Patients With Chronic Heart Failure: Results From Val-HeFT
Circulation, August 23, 2005; 112(8): 1121 - 1127.
[Abstract] [Full Text] [PDF]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2003 by the American College of Cardiology Foundation.